Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free SGMT Stock Alerts

Sagimet Biosciences (SGMT) Earnings Date, Estimates & Call Transcripts

Sagimet Biosciences logo
$10.25 +0.07 (+0.69%)
As of 08/21/2026 04:00 PM Eastern
Compare

Sagimet Biosciences Earnings Summary

Sagimet Biosciences issued Q2 2026 earnings on August 11, 2026, reporting an EPS of -$0.26, which missed the consensus estimate of -$0.25 by $0.01. With a trailing EPS of -$1.28, Sagimet Biosciences' earnings are expected to grow next year, from ($1.20) to ($1.11) per share.

Latest Q2
Earnings Date
Aug. 11Estimated
Consensus EPS
(Aug. 11)
-$0.25
Actual EPS
(Aug. 11)
-$0.26 Missed By -$0.01

Q2 2026 Earnings Resources

Powered by Quartr
Get Sagimet Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sagimet Biosciences and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

SGMT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Sagimet Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.45-$0.45-$0.45
Q2 20261-$0.31-$0.31-$0.31
Q3 20261-$0.26-$0.26-$0.26
Q4 20261-$0.32-$0.32-$0.32

Sagimet Biosciences Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026-$0.2510-$0.26 -$0.0090-$0.26--
5/12/2026Q1 2026-$0.39-$0.33+$0.06-$0.33--
3/11/2026Q4 2025-$0.43-$0.29+$0.14-$0.29--
11/13/2025Q3 2025-$0.41-$0.40+$0.01-$0.40--
8/13/2025Q2 2025-$0.52-$0.32+$0.20-$0.32--
5/8/2025Q1 2025-$0.79-$0.56+$0.23-$0.56--
3/12/2025Q4 2024-$0.65-$0.50+$0.15-$0.50--

Sagimet Biosciences Earnings - Frequently Asked Questions

Sagimet Biosciences (NASDAQ:SGMT) last announced its quarterly earning data on Tuesday, August 11, 2026. Learn more on SGMT's earnings history.

In the previous quarter, Sagimet Biosciences (NASDAQ:SGMT) missed the analysts' consensus estimate of ($0.25) by $0.01 with a reported earnings per share (EPS) of ($0.26). Learn more on analysts' earnings estimate vs. SGMT's actual earnings.

Sagimet Biosciences (NASDAQ:SGMT) has a recorded annual revenue of $2 million.

Sagimet Biosciences (NASDAQ:SGMT) has a recorded net income of -$51.04 million. SGMT has generated -$1.28 earnings per share over the last four quarters.

Sagimet Biosciences' earnings are expected to grow from ($1.20) per share to ($1.11) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:SGMT is sourced from Fiscal.ai, with the most recent quarter reported on 8/11/2026. New results are added as companies report their earnings.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel